Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
Rabah Redjoul, Anne Le Bouter, Vincent Parinet, Slim Fourati, Sébastien Maury
Topics & Concepts
MedicineHematopoietic stem cell transplantationVaccinationTransplantationAntibody responseImmune systemImmunologyCoronavirus disease 2019 (COVID-19)AntibodyHematopoietic cellHaematopoiesisStem cellInternal medicineDiseaseInfectious disease (medical specialty)BiologyGeneticsSARS-CoV-2 and COVID-19 ResearchHematopoietic Stem Cell TransplantationImmunotherapy and Immune Responses